Latest Articles

MWC investigators found new cancer therapy start-up TAMORx

MWC investigators found new cancer therapy start-up TAMORx

3 June 2022

MWC investigators Dr Joanna Mathy and Prof Rod Dunbar lead new cancer therapy drug research company, TAMORx, based upon MWC supported research and facilities.

read more

MWC researchers discover new path to potential anti-cancer, antibiotic drugs

MWC researchers discover new path to potential anti-cancer, antibiotic drugs

23 September 2020

A team of MWC investigators has gained some key new insights into the molecular assembly of certain anti-cancer and antibiotic molecules - paving the way for the design of more effective drugs to treat cancer or antibiotic-resistant superbugs.

read more

MWC melanoma research makes high impact

MWC melanoma research makes high impact

14 August 2020

Novel research by MWC investigators studying the effects of melanoma tumour in human lymph nodes has been selected for the front cover of Cancer Immunology Research journal's August 2020 issue.

read more

Kiwi scientists develop powerful melanoma research tool

Kiwi scientists develop powerful melanoma research tool

16 July 2020

A nationwide group of researchers from the Maurice Wilkins Centre has recently reported a detailed characterisation of one of the largest melanoma cell line panels ever developed that makes this a resource for research of international importance.

read more

New imaging improves our understanding of the immune system

New imaging improves our understanding of the immune system

4 March 2020

Maurice Wilkins Centre researchers have used novel imaging technology to reveal the structure and inner workings of entire lymph nodes, core components of the body’s immune system.

read more

Lung cancer drug poised for global approval, says MWC investigator

Lung cancer drug poised for global approval, says MWC investigator

11 December 2017

Dacomitinib, an irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor developed in collaboration with Pfizer by researchers led by MWC Associate Investigator Dr. Jeff Smaill, has shown significant efficacy in the treatment of patients with non-small-...

read more

Dr Aniruddha Chatterjee awarded Rutherford Discovery Fellowship

Dr Aniruddha Chatterjee awarded Rutherford Discovery Fellowship

13 October 2017

MWC Affiliate Investigator Dr Aniruddha Chatterjee of the University of Otago is one of only ten recipients across the country to be awarded a 2017 Rutherford Discovery Fellowship.

read more

Newly funded research highlights MWC collaborations

7 November 2016

Professor Gavin Painter from Victoria University’s Ferrier Research Institute has been awarded funding in the Ministry of Business, Innovation and Employment’s 2016 Endeavour Fund science investment round. 

read more